Physician profile
Melissa Anne Ochoa
NPI 1730435546
$28,205.07
in general payments reported to CMS, 2019-2025
62 companies · $4,975 in 2025
The $4,975 reported for 2025 was more than what 99% of Obstetric, Inpatient providers received nationally (typical 2025 total: $94.16).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,384 · 2022: $5,325 · 2023: $6,675 · 2024: $6,846 · 2025: $4,975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Consulting Fee: $660 · Education: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,424.58 |
| Consulting Fee | $660.00 |
| Education | $411.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $3,947.54 | 2021-2025 | Tysabri, Vumerity, Leqembi |
| Emd Serono, INC. | $2,971.73 | 2021-2025 | Mavenclad, Mavenclad |
| Alexion Pharmaceuticals, INC. | $2,566.92 | 2021-2025 | Ultomiris, Soliris |
| Abbvie INC. | $1,819.93 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,401.66 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Lilly USA, LLC | $1,318.08 | 2021-2025 | Emgality, Amyvid, Reyvow |
| Pfizer INC. | $1,056.86 | 2022-2025 | |
| Lundbeck LLC | $998.95 | 2021-2025 | Vyepti, Rexulti |
| Tg Therapeutics, INC. | $986.55 | 2023-2025 | |
| Eisai INC. | $902.01 | 2021-2025 | |
| Ucb, INC. | $715.13 | 2021-2024 | Rystiggo, Zilbrysq, Briviact |
| Amneal Pharmaceuticals LLC | $610.91 | 2022-2025 | Rytary, Crexont, Ongentys 50mg Capsules 30 |
| Harmony Biosciences LLC | $549.88 | 2021-2025 | Wakix |
| Grifols USA, LLC | $523.25 | 2021-2025 | Gamunex-C |
| Novartis Pharmaceuticals Corporation | $520.42 | 2021-2025 |
Show all 62 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Ochoa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.